FADS1 (Fatty Acid Desaturase 1) and FADS2 (Fatty Acid Desaturase 2) were previously reported to reduce lipid accumulation and influence the NAFLD process in mice [21–25]. This evidence concerns the gene FADS2 and metabolic dysfunction-associated steatotic liver disease.